Aptorum Group Limited (APM) - News Archive

Showing 3 of 3 results.

Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement

NEW YORK, July 16, 2025—In a significant move to enhance its position in the biopharmaceutical landscape, Aptorum Group Limited (NASDAQ: APM) has announced a definitive agreement for an all-stock merger with DiamiR Bios...

Jul 16, 2025 • Major Pharmaceutical Preparations Industry Merger and Acquisition DiamiR

Aptorum Group Limited’s $3 Million Offering A Strategic Step Forward Amid Financial Challenges,

Aptorum Group’s Strategic Offering Amidst Challenging Revenue LandscapeIn a significant move signaling its commitment to advancing critical biomedical solutions, Aptorum Group Limited has announced a registered direct o...

Jan 3, 2025 Announcement #AptorumGroupLtdNote

Aptorum Group Stays the Course: Reports Solid Financial Results and Steady Progress for the First Half of 2023

Aptorum Group Limited, a pioneering NASDAQ-listed clinical stage biopharmaceutical throng, has fostered a business update alongside its financial results for the first six months ending June 30, 2023. With a sprawling p...

Dec 22, 2023 • Major Pharmaceutical Preparations Industry Business Update NASDAQ